Hungary-based, Gedeon Richter in a multi-year agreement plans to adopt Phase Forward’s Clintrial product for its clinical trial data management activities.
Gyorgy Nemeth, medical director at Gedeon Richter, said: “After an intense review process, Phase Forward’s dedicated services organisation and proven Clintrial product made our decision a clear one. We know that we are collaborating with the premier technology provider for clinical trials – and we look forward to garnering the benefits inherent in greater drug trial efficiencies.”
Steve Powell, senior vice president at Phase Forward, said: “We’re proud to be working with Gedeon Richter, one of Central-Eastern Europe’s leading pharmaceutical companies and an organisation dedicated to the kind of drug development work that will lead to much-needed new and generic therapies. It’s gratifying to have a company of Gedeon Richter’s reputation choose Phase Forward after such an extensive, thorough review process.”